A group of investigators studied the potential of three soluble biomarkers for BPD prediction in umbilical CB and in peripheral blood (PB): soluble ST2 (sST2), interleukin 33 (IL-33), and soluble urokinase plasminogen activator receptor (suPAR). The gene discussed is IL33; the disease is bronchopulmonary dysplasia.